01 1Curia Italy S.r.l.
01 1NYPRG-101
01 1U.S.A
NDC Package Code : 55486-1605
Start Marketing Date : 2023-09-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
68
PharmaCompass offers a list of 2-Bromo-Lysergic Acid Diethylamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 2-Bromo-Lysergic Acid Diethylamide manufacturer or 2-Bromo-Lysergic Acid Diethylamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 2-Bromo-Lysergic Acid Diethylamide manufacturer or 2-Bromo-Lysergic Acid Diethylamide supplier.
PharmaCompass also assists you with knowing the 2-Bromo-Lysergic Acid Diethylamide API Price utilized in the formulation of products. 2-Bromo-Lysergic Acid Diethylamide API Price is not always fixed or binding as the 2-Bromo-Lysergic Acid Diethylamide Price is obtained through a variety of data sources. The 2-Bromo-Lysergic Acid Diethylamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bromolysergide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bromolysergide, including repackagers and relabelers. The FDA regulates Bromolysergide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bromolysergide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bromolysergide supplier is an individual or a company that provides Bromolysergide active pharmaceutical ingredient (API) or Bromolysergide finished formulations upon request. The Bromolysergide suppliers may include Bromolysergide API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bromolysergide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bromolysergide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bromolysergide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bromolysergide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bromolysergide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bromolysergide suppliers with NDC on PharmaCompass.
